BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18267927)

  • 41. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies.
    de Vries AC; Kuipers EJ
    Helicobacter; 2007 Nov; 12 Suppl 2():22-31. PubMed ID: 17991173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Helicobacter pylori and gastric cancer: eradication to prevent cancer?].
    Courillon-Mallet A
    Gastroenterol Clin Biol; 2009 Apr; 33(4):301-5. PubMed ID: 19324504
    [No Abstract]   [Full Text] [Related]  

  • 43. [Prevention of gastric cancer by Helicobacter pylori eradication].
    Asaka M
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1223-7. PubMed ID: 19692758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer.
    Kim CG; Choi IJ; Lee JY; Cho SJ; Nam BH; Kook MC; Hong EK; Kim YW
    J Gastroenterol Hepatol; 2009 Mar; 24(3):469-74. PubMed ID: 19067779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Helicobacter pylori heat shock protein 60 antibodies are associated with gastric cancer.
    Tanaka A; Kamada T; Yokota K; Shiotani A; Hata J; Oguma K; Haruma K
    Pathol Res Pract; 2009; 205(10):690-4. PubMed ID: 19450936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil.
    Motta CR; Cunha MP; Queiroz DM; Cruz FW; Guerra EJ; Mota RM; Braga LL
    Digestion; 2008; 78(1):3-8. PubMed ID: 18689994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteomic identification of biomarkers related to Helicobacter pylori-associated gastroduodenal disease: challenges and opportunities.
    Wu MS; Chow LP; Lin JT; Chiou SH
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1657-61. PubMed ID: 19120858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Helicobacter pylori: host genetics and disease outcomes.
    Snaith A; El-Omar EM
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):577-85. PubMed ID: 19072405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Helicobacter pylori infection, host genetics and gastric cancer.
    Shanks AM; El-Omar EM
    J Dig Dis; 2009 Aug; 10(3):157-64. PubMed ID: 19659782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Helicobacter pylori infection on IL-8, IL-1beta and COX-2 expression in patients with chronic gastritis and gastric cancer.
    Bartchewsky W; Martini MR; Masiero M; Squassoni AC; Alvarez MC; Ladeira MS; Salvatore D; Trevisan M; Pedrazzoli J; Ribeiro ML
    Scand J Gastroenterol; 2009; 44(2):153-61. PubMed ID: 18985541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiology of gastric cancer.
    Plummer M; Franceschi S; Muñoz N
    IARC Sci Publ; 2004; (157):311-26. PubMed ID: 15055304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Host-bacterial interactions in Helicobacter pylori infection.
    Amieva MR; El-Omar EM
    Gastroenterology; 2008 Jan; 134(1):306-23. PubMed ID: 18166359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
    Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
    Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Helicobacter pylori infection and family history of gastric cancer decrease expression of FHIT tumor suppressor gene in gastric mucosa of dyspeptic patients.
    Stec-Michalska K; Peczek L; Michalski B; Wisniewska-Jarosinska M; Krakowiak A; Nawrot B
    Helicobacter; 2009 Oct; 14(5):126-34. PubMed ID: 19751438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammation, immunity, and vaccines for Helicobacter pylori.
    D'Elios MM; Andersen LP
    Helicobacter; 2009 Sep; 14 Suppl 1():21-8. PubMed ID: 19712164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.
    Sawaya M; Yoshimura T; Shimoyama T; Munakata A; Fukuda S
    J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Helicobacter pylori eradication for the prevention of gastric cancer: always, sometimes or never?].
    Fischbach W
    MMW Fortschr Med; 2009 Jun; 151(26-29):43-5. PubMed ID: 19739549
    [No Abstract]   [Full Text] [Related]  

  • 59. Helicobacter pylori immunology and vaccines.
    Vorobjova T; Watanabe T; Chiba T
    Helicobacter; 2008 Oct; 13 Suppl 1():18-22. PubMed ID: 18783517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low prevalence of Helicobacter pylori infection in patients with gastric cancer.
    Popescu M; Dumitraşcu DL; Pascu O
    Rom J Intern Med; 2007; 45(3):259-62. PubMed ID: 18333358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.